Comparing treatments for chronic hives
Part of Immune system & allergy, Skin clinical trials.
This study tests different treatment options for people with chronic hives (urticaria) that have lasted more than 6 weeks. It aims to find which treatment works best and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 60 years old.
- You have had hives (urticaria) for more than 6 weeks.
- You are not pregnant or breastfeeding.
- You do not have a weakened immune system.
- You do not have chronic liver or kidney disease.
- You have not taken steroid medications in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at how well the drug Histoglob (Immunoglobulin-Histamine Complex) works for people with chronic urticaria (hives that last a long time). It's for patients who are already on a first-line treatment and are starting Histoglob for the first time as part of their regular care.
This trial tests if an injection of your own blood can help treat chronic hives that haven't improved with high doses of antihistamines. You may be eligible if you have had hives for a long time and standard treatments haven't worked.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
This trial tests an injectable medication (cetirizine, a type of antihistamine) to see if it quickly relieves itching and hives in adults with acute (short-term) hives. It is for people whose hives have lasted less than 6 weeks and who still have bothersome symptoms.
This trial tests a new medication called THB335 for people with chronic spontaneous urticaria (CSU), which causes hives and itching for months without a clear cause. The study will see if the drug can reduce hives and itching better than a placebo (a pill with no active medicine).
Hear when a new Chronic Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.